INS and diabetes mellitus: For example, pharmacological approaches that target the hypomethylation environment established in the diabetic detrusor or the use of epigenomic data to identify “actionable therapeutic targets”; genes in loci which diabetes results in modulated methylation patterns and protein expression that are not normalized by insulin treatment and are therefore the most likely targets for hyperglycemic memory.